The Hyris System™ Detects SARS-CoV-2, Including Recently Emerged Variants of Concerns.
14 sept. 2021 04h00 HE | Hyris
LONDON, England, Sept. 14, 2021 (GLOBE NEWSWIRE) -- New mutations of SARS-CoV-2 worldwide are causing several concerns regarding further disruption of public safety. Authorities involved in the...
LogoPressRelease.jpg
Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference
02 sept. 2021 08h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Anpac Bio LOGO.jpg
AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO
17 août 2021 07h30 HE | AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations...
LogoPressRelease.jpg
Fluidigm to Participate in UBS Genomics 2.0 and MedTech Innovations Summit
09 août 2021 11h14 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
ScipherTM.png
Scipher Medicine Increases Patient Access for Prismra® by Expanding Intended Use in Autoimmune Patients
29 juil. 2021 09h22 HE | Scipher Medicine Corporation
Expanded intended use for the blood test validated in Network-004 study.Now, most rheumatoid arthritis patients can be tested at any point in their clinical journey.Test enables providers to identify...
ScipherTM.png
Scipher Medicine Announces PrismRA® Met Primary and Secondary Endpoints in Prospective Observational Study Predicting Inadequate Response to World’s Largest-Selling Drug Class
24 juin 2021 08h00 HE | Scipher Medicine Corporation
Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with TherapyProviders Can Access Patient-Specific Data for Optimized Therapy Selection WALTHAM, Mass., June 24, 2021 ...
Xphyto logo.jpg
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO of XPhyto Therapeutics Corp.
17 juin 2021 09h00 HE | XPhyto Therapeutics Corp.
NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
PhigenixMainLogo 2018.jpg
Phigenix, Inc. Announces Issuance of U.S. Patent Covering Precision Medicine Diagnostic and Novel Therapeutic for Treating Drug-Resistant Breast Cancer
15 juin 2021 12h17 HE | Phigenix, Inc.
ATLANTA, June 15, 2021 (GLOBE NEWSWIRE) -- Phigenix, Inc. Pharmaceutical and Biomedical Research Company, a molecular oncologist-led, biopharmaceutical company focused on identifying, developing,...
ScipherTM.png
Scipher Medicine Presents New Data at the European League Against Rheumatism (EULAR) 2021 Further Validating PrismRA® Test
15 juin 2021 08h00 HE | Scipher Medicine Corporation
Molecular signature test predicts likelihood of non-response to adalimumab or etanercept, two of the world’s most expensive medications, in an independent validation cohort PrismRA demonstrates a more...
Federal report calls for DOJ, HHS adoption of federal accessibility standards for medical and diagnostic equipment
20 mai 2021 12h08 HE | National Council on Disability
WASHINGTON, May 20, 2021 (GLOBE NEWSWIRE) -- Today, the National Council on Disability (NCD)--an independent federal agency--released a report focused on much needed federal regulations that would...